Xeljanz 5 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FM48S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,453
Award facts
- Contract value 100% obligated
- $44,452.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for $44,452.61 to supply 60 units of Xeljanz 5 mg tablets. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 29, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031.
The underlying IDC serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems globally, covering a broad range of prescription medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Xeljanz (tofacitinib) is a Janus kinase inhibitor used primarily for treating rheumatoid arthritis and other inflammatory conditions, supporting the Defense Health Agency's medical treatment facility requirements. Cencora, Inc. competes on a full and open basis for federal pharmaceutical contracts and has demonstrated consistent capability in fulfilling critical medical supply needs for military personnel and veterans through its extensive federal contract portfolio with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FM48S?
SPE2DR26FM48S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FM48S worth?
The government has obligated $44,453 on SPE2DR26FM48S.
Is contract SPE2DR26FM48S an order under another contract?
Yes. SPE2DR26FM48S is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM48S competed?
The extent of competition for SPE2DR26FM48S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award